Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Upstream Processing

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

Bioreactor Design and Operational System

Bioreactor Design and Operational System

Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Deep Learning-Guided Reverse Translation Enhances Soluble Expression of Recombinant Proteins in <i>Escherichia coli</i>.

International journal of molecular sciences·2026

Same author

Understanding the Catalytic Determinant role of Diaphorase-Like Subunit in Formate Dehydrogenases via Redox Couples.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same author

An interfacial-intramolecular electron highway for accelerated electrocatalytic CO<sub>2</sub> reduction by an O<sub>2</sub>-tolerant formate dehydrogenase.

Nature communications·2026

Same author

Characterization and Application of a Thermostable HAD Phosphatase From Thermophilibacter mediterraneus for Glucosamine Production.

Biotechnology journal·2025

Same author

Protein Engineering of an Inositol-1-phosphate Synthase Based on the Active-Site Redesign Facilitates the Biomanufacturing of <i>myo</i>-Inositol from Starch <i>via</i> <i>In Vitro</i> Synthetic Enzymatic Biosystem.

Journal of agricultural and food chemistry·2025

Same author

Efficient Biosynthesis of Polyhydroxybutyrate from Xylose via an In Vitro Synthetic Enzymatic Biosystem with Self-Sustained Cofactor Regeneration.

Chembiochem : a European journal of chemical biology·2025

Search research articles

Related Experiment Video

Updated: May 17, 2026

Rapid, Affordable, and Uncomplicated Production of Bacterial Cell-free Lysate

Rapid, Affordable, and Uncomplicated Production of Bacterial Cell-free Lysate

Published on: October 29, 2021

Cell-free biosystems for biomanufacturing.

Chun You¹, Y-H Percival Zhang

¹Biological Systems Engineering Department, Virginia Tech, 304 Seitz Hall, Blacksburg, VA, 24061, USA.

Advances in Biochemical Engineering/Biotechnology

|November 1, 2012

Summary

This summary is machine-generated.

Cell-free biosystems, defined as systems with over three catalytic components, offer a powerful platform for biomanufacturing. These systems show potential to disrupt microbial fermentation for producing valuable chemicals and drugs.

More Related Videos

Rapid, Enzymatic Methods for Amplification of Minimal, Linear Templates for Protein Prototyping using Cell-Free Systems

Rapid, Enzymatic Methods for Amplification of Minimal, Linear Templates for Protein Prototyping using Cell-Free Systems

Published on: June 14, 2021

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Related Experiment Videos

Last Updated: May 17, 2026

Rapid, Affordable, and Uncomplicated Production of Bacterial Cell-free Lysate

Rapid, Affordable, and Uncomplicated Production of Bacterial Cell-free Lysate

Published on: October 29, 2021

Rapid, Enzymatic Methods for Amplification of Minimal, Linear Templates for Protein Prototyping using Cell-Free Systems

Rapid, Enzymatic Methods for Amplification of Minimal, Linear Templates for Protein Prototyping using Cell-Free Systems

Published on: June 14, 2021

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Area of Science:

Biotechnology
Biomanufacturing
Synthetic Biology

Background:

Cell-free biosystems have a century-long history in biological research.
They are emerging as a versatile platform for biomanufacturing diverse products.

Purpose of the Study:

To define cell-free biosystems with multiple catalytic components.
To compare cell-free systems with living organisms for biomanufacturing.
To analyze challenges and solutions for scaling up cell-free biosystems.

Main Methods:

Comparative analysis of cell-free systems versus living organisms.
Review of historical development and current applications of cell-free biosystems.
Identification of scale-up obstacles and proposed solutions.

Main Results:

Cell-free biosystems with >3 catalytic components extend multienzymatic biocatalysis.
Advantages and disadvantages of cell-free systems vs. living organisms were detailed.
Key examples and scale-up challenges were highlighted.

Conclusions:

Cell-free biosystems offer high product yields and potentially low costs.
They represent a disruptive technology for microbial fermentation.
Potential for producing biocommodities, fine chemicals, and pharmaceuticals.